AmberGen
AmberGen’s MaxOmic™ Lab provides advanced spatial biology services for drug developers, ranging from focused spatial imaging of drug biodistribution to fully integrated, highly multiomic preclinical studies. Our platform enables same-sample, same-instrument imaging of three major drug classes—small molecules, oligonucleotide therapeutics, and antibody-based drugs, including ADCs—combined with proteins, RNA, lipids, metabolites, and glycans. AI-powered correlative multiomic analyses transform these data into actionable mechanistic insight that accelerates development and de-risks critical decisions.
